
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
Magnetic iron oxide nanotubes (MNTS) are a form of nanomaterials composed of iron oxide nanoparticles and other metals that form a hollow, cylindrical structure. The small size of MNTS, coupled with their magnetic properties, makes them highly useful in a wide range of applications, from medical diagnostics to energy storage.
MNTS have a wide range of potential applications due to their unique properties, including their high surface area, electrical conductivity, and magnetic properties. They can be used in biomedical imaging and diagnostics, since they can be readily detected by MRI scanners.
They can also be used as a form of energy storage, due to their high surface area and magnetic properties. Additionally, MNTS can be used for drug delivery and as catalysts in chemical reactions. MNTS are created through a variety of techniques, such as sputtering, electrospinning, and chemical vapor deposition.
Depending on the process used, MNTS can have different morphologies, such as multiwalled nanotubes or single-walled nanotubes, and can be composed of different metals or alloys.
MNTS have the potential to revolutionize many industries, such as energy storage, biomedical imaging, and drug delivery. They are also relatively easy to produce and can be customized for various applications.
While much research has been conducted on MNTS, more work is needed to further explore their potential uses and develop better fabrication techniques.
The Global Magnetic Iron Oxide Nanotube market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Superparamagnetic iron oxide nanoparticles, or Fe3O4 NPs, are receiving a lot of attention for their potential use in biomedical applications like drug administration, cell labelling, biosensing, hyperthermia, and magnetic resonance imaging (MRI).
Fe3O4 NPs have a very low toxicity and are biocompatible in addition to their size-selective production and practical basic magnetic characteristics. The packing of numerous magnetic nanocrystals in a well-defined host material and the resulting influence on physical properties are of fundamental interest.
For this reason, high surface area elemental silicon (Si) in the form of porous Si NPs or silicon nanotubes (Si NTs) with homogeneous architectures and well-defined sizes is an attractive choice.
Relativity metrics r1 or r2, which indicate a contrast agent's capacity to reduce water's T1 or T2 relaxation time, are commonly used to assess an MRI contrast agent's distinctive quality. Presently, Gd-complex based T1 MRI contrast agents are the most widely used class of contrast agents.
In recent years, there has been a significant focus on the creation of nanoparticulate T1 contrast agents that contain Gd3+ or Mn2+ ions. However, toxicity issues with these NP-based T1 contrast agents continue to exist, which is driving more research in the direction of developing novel substitutes. Fe3O4 is the option with the best biocompatibility when compared to the gadolinium-based compounds.
The possible enhancement of Fe3O4 MRI contrast agents is determined by various factors, including (i) NP size; (ii) composition; (iii) surface coating; and (iv) synergistic magnetic effects resulting from the presence of multiple superparamagnetic Fe3O4 NP centres in a relatively small volume.
Fe3O4 MRI contrast agents are classified as negative contrast agents, also known as r2 weighted. Fe3O4 NPs have been functionalized with various surface moieties for MRI applications in order to improve their solubility.
The formation of additional structures, such as Fe3O4 nanorods and clusters of individual Fe3O4 NPs, has similarly boosted the local concentration of Fe3O4 in solution. On the other hand, these clusters frequently lack homogeneity and a distinct three-dimensional structure
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |